Hudson Bay Capital Management »

Acelyrin shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Acelyrin (SLRN) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Acelyrin

Tip: Access up to 7 years of quarterly data

All positions including Acelyrin held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acelyrin by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $617k 197k 3.14
2024-09-30 $986k 200k 4.93

More positions owned by Hudson Bay Capital Management

NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Amazon Call Option (AMZN)
Apple Call Option (AAPL)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Microsoft Corporation Call Option (MSFT)
Advanced Micro Devices Put Option (AMD)
Royal Caribbean Group Note 6.000% 8/1 (Principal)
Berkshire Hathaway Inc Del Cl B New Put Option (BRK.B)
Eli Lilly & Co. Call Option (LLY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
UnitedHealth Put Option (UNH)
Taiwan Semiconductor Mfg Sponsored Ads Put Option (TSM)
Microstrategy Cl A New Call Option (MSTR)
Dollar Tree Put Option (DLTR)

View all positions for Hudson Bay Capital Management

Top funds holding Acelyrin

T. Rowe Price Investment Management
AyurMaya Capital Management Company
BlackRock
Millennium Management
Citadel Advisors
Vanguard Group
OrbiMed Advisors
venBio Partners
Tybourne Capital Management
Blue Owl Capital Holdings
General Atlantic
Samsara BioCapital
Morgan Stanley
Opaleye Management
Palo Alto Investors

View all funds holding Acelyrin